169331 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
#2402Biochemical-immunological hybrid biosensor and sensor system including the same
#2403Nicotinamide compositions and the therapeutic use thereof
#2404Methods of identifying schizophrenia patients at risk for relapse
#2405PATHWAY SPECIFIC ASSAYS FOR PREDICTING IRRITABLE BOWEL SYNDROME DIAGNOSIS
#2406Citrullinated proteins: a post-translated modification of myocardial proteins as marker of physiological and pathological disease
#2407Method, Array and Use for Determining the Presence of Pancreatic Cancer
#2408Adipocyte-derived exosomes, and compositions, kits, and methods of using the same for detection and screening
#2409BIOMARKERS FOR PREDICTING DEGREE OF WEIGHT LOSS IN MALE SUBJECTS
#2410IN-VITRO METHOD AND KIT FOR DIAGNOSING THE RISK OF SUFFERING FROM CARIES
#2411METHOD FOR DIAGNOSING AN INFLAMMATORY DISORDER
#2412Blood biomarkers for appendicitis and diagnostics methods using biomarkers
#2413Human monoclonal antibodies specific for glypican-3 and use thereof
#2414Monoclonal antibodies to human fibroblast growth factor receptor 2 (HFGFR2) and methods of use thereof
#2415Tuberculosis biomarkers and uses thereof
#2416Method for predicting the risk of incidence of chronic kidney disease
#2417Therapy
#2418Bi-functional arginine-glycine-aspartic acid (RGD) peptides and methods to promote angiogenesis
#2419Serum biomarker panels for bipolar disorder
#2420BIOMARKER FOR PSYCHIATRIC AND NEUROLOGICAL DISORDERS
#2421Method for estimating number of podocytes in urine
#2422METHODS FOR DIAGNOSIS AND PROGNOSIS OF EPITHELIAL CANCERS
#2423Method for the in vitro prediction of the probability of a patient developing severe dengue, based on a blood sample
#2424ASSAY FOR THE DIAGNOSIS OF MACULAR DEGENERATION
#2425C-CBL MUTATIONS AND USES THEREOF
#2426HYBRID CHIMERA POLYPEPTIDES AS DUAL INHIBITORS OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR AND PLATELET-DERIVED GROWTH FACTOR RECEPTOR
#2427Kit for in vitro or ex vivo measurement of SCD127 expression in a biological sample
#2428COMPOSITIONS AND METHODS FOR DETECTING AND TREATING PERIODONTAL DISEASE
#2429PROTEIN BIOMARKERS AND THERAPEUTIC TARGETS FOR RENAL DISORDERS
#2430METHOD FOR MEASURING GLYCOPROTEIN, METHOD FOR EXAMINING LIVER DISEASE, REAGENT FOR QUANTITATIVE DETERMINATION OF GLYCOPROTEIN, AND GLYCAN-MARKER GLYCOPROTEIN AS AN INDEX FOR CLINICAL CONDITIONS OF LIVER DISEASE
#2431System and method for immediate health assessment response system
#2432System and method for collection and dissemination of biologic sample test results data
#2433Method for Discriminating Symptom of Hepatic Disease
#2434DIAGNOSIS AND MONITORING OF CHRONIC RENAL DISEASE USING NGAL
#2435Highly Sensitive System and Methods for Analysis of Troponin
#2436Methods to Diagnose, Treat and Prevent Bone Loss
#2437Dissolved protein arthritis markers
#2438Prediction of the risk of developing a disseminated infection for patients admitted to an intensive care unit
#2439Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#2440Diagnostics for pulmonary arterial hypertension and sudden cardiac death
#2441INHIBITION OF AXL/GAS6 SIGNALING IN THE TREATMENT OF LIVER FIBROSIS
#2442Glycosidase inhibitors
#2443Methods and kits for determining von willebrand factor activity in the absence of ristocetin
#2444Method of differentiating stable angina pectoris from acute coronary syndrome and diagnostic kit thereof
#2445Composition comprising prostacyclin andor analogues thereof for treatment of acute critically ill patients
#2446METHOD OF IDENTIFYING PROTEINS IN HUMAN SERUM INDICATIVE OF PATHOLOGIES OF HUMAN LUNG TISSUES
#2447IMMUNOLOGICAL MEASUREMENT METHOD FOR L-FABP AND MEASUREMENT REAGENT USED IN SAID METHOD
#2448Use of Tetraspanin-2 for Treating Diabetes and Screening an Anti-diabetic agent
#2449SAB as a biomarker for degenerative diseases and therapeutic sensitivity in cancers
#2450Compositions and methods for sjögren's syndrome
#2451Modulation of epigenetic stress response
#2452KITS FOR INDENTIFYING AND TREATING SUBJECTS RESISTANT TO ACETYL SALICYLIC ACID
#2453Targeting cGMP-related phosphodiesterases to reduce cyst formation in cystic kidney disease, and related materials and methods
#2454GASTRO-RETENTIVE DRUG DELIVERY SYSTEM
#2455RATIO BASED BIOMARKERS AND METHODS OF USE THEREOF
#2456Biomarker for barrett's oesophagus
#2457HOMOGENOUS AND HETEROGENEOUS ASSAYS AND SYSTEMS FOR DETERMINATION OF OCULAR BIOMARKERS
#2458Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#2459Device for detecting toxic shock syndrome toxins and method of making the same
#2460Use of anoctamin as a biomarker for radiation biodosimetry
#2461Use of VAP-1 inhibitors for treating fibrotic conditions
#2462Methods and Compositions for the Treatment of Symptoms of Complex Regional Pain Syndrome
#2463Carbazole-containing sulfonamides as cryptochrome modulators
#2464Treatment of circadian rhythm disorders
#2465Compositions and methods for metabolic profiling in subjects with heart failure with preserved ejection fraction
#2466METHODS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#2467Attractin and lumican biomarkers in idiopathic pneumonia syndrome
#2468Compositions and Methods for Identifying and Modulating Metabolic Health
#2469Biomarkers for diagnosis and prognosis of corneal ectatic disorders
#2470DIAGNOSTIC METHOD
#2471Compositions, methods and kits for diagnosis of lung cancer
#2472Assays for IGFBP7 having improved performance in biological samples
#2473CLASS I MHC PHOSPHOPEPTIDES FOR CANCER IMMUNOTHERAPY AND DIAGNOSIS
#2474Methods for the diagnosis and treatment of Sjögren's syndrome
#2475Compositions and methods for the treatment of fatty acid metabolism disorders
#2476IDENTIFICATION, MONITORING AND TREATMENT OF INFECTIOUS DISEASE AND CHARACTERIZATION OF INFLAMMATORY CONDITIONS RELATED TO INFECTIOUS DISEASE USING GENE EXPRESSION PROFILES
#2477NOVEL MARKER FOR GESTATIONAL DIABETES
#2478Method and kit for diagnosing depression after acute coronary syndrome using homocysteine
#2479Compositions and methods for identifying depressive disorders
#2480BLOOD RNA BIOMARKERS OF CORONARY ARTERY DISEASE
#2481ARRDC1-mediated microvesicles (ARMMS) and uses thereof
#2482Neuropilin-1 specific binding peptide, fusion protein fused with same, and use thereof
#2483Biomarkers
#2484Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye
#2485Pancreatic cancer biomarkers and uses thereof
#2486Methods of use for intermediate filament protein probes
#2487METHODS FOR DETECTING ADVERSE LOCAL TISSUE REACTION (ALTR) NECROSIS
#2488Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
#2489COMPOSITION FOR DIAGNOSING SKIN DAMAGE CAUSED BY FINE DUST, AND COMPOSITION COMPRISING GALANGIN AS ACTIVE INGREDIENT
#2490Methods for diagnosing and reducing incidences of cardiac allograft rejection
#249113+/17+ BIN1 expression as a marker of cardiac disorders
#2492USE OF NHE3 AS A BIOMARKER FOR RADIATION BIODOSIMETRY
#2493BIOMARKERS FOR PREDICTING DEGREE OF WEIGHT LOSS
#2494Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases
#2495Dermatopontin as a therapeutic for metabolic disorders
#2496Methods and compositions for identifying non-alcoholic fatty liver disease
#2497Method and kit for the detection of pancreatic dysfunction
#2498Free histone proteins as biomarkers
#2499Method for diagnosing a molecular phenotype of a patient suffering from an illness accompanied by chronic inflammation
#2500USE OF MARKERS IN THE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER
#2501METHOD FOR PREDICTING THE RESPONSE TO HER2-DIRECTED THERAPY
#2502BIOPLASMONIC DETECTION OF BIOMARKERS IN BODY FLUIDS USING PEPTIDE RECOGNITION ELEMENTS
#2503Biomarkers predictive of predisposition to depression and response to treatment
#2504BIOMARKER FOR DIAGNOSIS OF MOYAMOYA DISEASE
#2505Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability
#2506Device and method for detecting a target analyte
#2507Semaphorin 3A for treatment and assessment of severity of inflammatory bowel disease
#2508INHIBITORS OF INDUCED MMP-1 PRODUCTION
#2509PREDICTIVE MARKERS OF IBD
#2510PROTEIN AND LIPID BIOMARKERS PROVIDING CONSISTENT IMPROVEMENT TO THE PREDICTION OF TYPE 2 DIABETES
#2511MULTIFUNCTIONAL MAGNETO-POLYMERIC NANOSYSTEMS FOR RAPID TARGETING, ISOLATION, DETECTION AND SIMULTANEOUS IMAGING OF CIRCULATING TUMOR CELLS
#2512THERMOELECTRIC SENSOR FOR ANALYTES IN A GAS AND RELATED METHOD
#2513Articles for diagnosis of liver fibrosis
#2514SYSTEMS AND METHODS FOR DETERMINING RETINAL GANGLION CELL POPULATIONS AND ASSOCIATED TREATMENTS
#2515Biomarkers related to kidney function and methods involving their use
#2516Methods for evaluation of the effectiveness of a drug or drug candidate in treating an inflammatory bowel disease by use of multiplexed assay kit comprising various biomarkers
#2517Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
#2518COMPOUNDS AND METHODS FOR THE DETECTION OF CALPROTECTIN
#2519HISTONE PROTEIN UBIQUITINATION AS A CANCER BIOMARKER
#2520Method for the early diagnosis of a pre-diabetic state and type 2 diabetes
#2521Methods for early identification of bone healing ability in injured patients
#2522Methods for treating or preventing asthma by administering an IL-4R antagonist
#2523Method of diagnosing and treating asphyxia
#2524NOVEL DIAGNOSTIC AND THERAPEUTIC TARGET IN INFLAMMATORY AND/OR CARDIOVASCULAR DISEASES
#2525Diagnosis of leukocyte-mediated disease and halogen gas exposure
#2526Biomarkers useful in liver fibrosis diagnosis
#2527Metabolite Biomarkers Predictive Of Renal Disease In Diabetic Patients
#2528Non-invasive biomarker to identify subject at risk of preterm delivery
#2529Nanoparticle probes and methods of making and use thereof
#2530TREATMENT OF HUTCHINSON-GILFORD PROGERIA SYNDROME AND DISEASES RELATED TO VASCULAR AGEING
#2531Method and compositions for reducing immunorecognition of dietary protein
#2532Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders
#2533Sialylated fetuin-A as a marker of immunotherapy efficacy
#2534Biomarkers useful in the treatment of subjects having diseases of the eye
#2535GALECTIN-3 IMMUNOASSAY
#2536PROGNOSIS OF ADVERSE EVENTS IN PATIENTS WITH SUSPECTED CHRONIC HEART FAILURE
#2537Device and associated methods for performing luminescence and fluorescence measurements of a sample
#2538Method for determining the distinctive nutritional requirements of a patient
#2539Device and associated methods for performing luminescence and fluorescence measurements of a sample
#2540ADAM12 inhibitors and their use against inflammation-induced fibrosis
#2541Diagnostics and Therapeutics for Diseases Associated With G-Protein Coupled Receptor AdipoR2 (AdipoR2)
#2542Compositions and methods for the prevention and treatment of mast cell-induced vascular leakage
#2543Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#2544Methods and devices for female health monitoring
#2545Animal model for non alcoholic steato hepatitis and liver fibrosis
#2546TEM-1 diagnostic antibodies
#2547Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof
#2548Methods for modular synthesis of N-glycans and arrays thereof
#2549CHEMICAL MODEL OF A NEURODEGENERATIVE DISEASE, METHOD FOR PREPARATION AND USES OF SAME
#2550DIAGNOSING AND TREATING IGA NEPHROPATHY
#2551Diagnostic method employing HNL
#2552BLADDER CANCER PROGNOSIS
#2553Blood biomarkers for appendicitis and diagnostics methods using biomarkers
#2554OLIGONUCLEOTIDE PROBES AND USES THEREOF
#2555COLON DISEASE TARGETS AND USES THEREOF
#2556Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#2557Determination of glycosaminoglycan levels by mass spectrometry
#2558METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING DISEASES
#2559DIAGNOSTIC MARKERS FOR CROHN'S DISEASE
#2560Multiple-variable IL-2 dose regimen for treating immune disorders
#2561Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#2562Diagnostic and therapeutic methods and products related to anxiety disorders
#2563USE OF 5-METHOXYTRYPTOPHAN AS DIAGNOSTIC AGENT OF INFLAMMATORY DISEASES
#2564Methods, Devices, Kits and Compositions For Detecting Roundworm, Whipworm and Hookworm
#2565Methods for the prevention and the treatment of extracapillary glomerulonephritis
#2566METHODS FOR ASSESSING VAGINAL ATROPHY
#2567Non-invasive method for assessing liver fibrosis progression
#2568METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#2569METHODS AND KITS FOR TREATING CARDIOVASCULAR DISEASES
#2570Quinoline-3-carboxamide compounds and their use in diagnosis
#2571Compositions and methods for inhibiting fibrosis
#2572PIRFENIDONE TREATMENT FOR PATIENTS WITH ATYPICAL LIVER FUNCTION
#2573CITRULLINATED PROTEINS: A POST-TRANSLATED MODIFICATION OF MYOCARDIAL PROTEINS AS MARKER OF PHYSIOLOGICAL AND PATHOLOGICAL DISEASE
#2574BIOMARKERS OF FAST PROGRESSION OF CHRONIC KIDNEY DISEASE
#2575Detection of activated monocytes in human peripheral blood and determining the concentration of cell surface integrin using plasmon amplified raman detection
#2576Compositions and methods for treating heart failure
#2577Use of 1,25-dihydroxyvitamin D values in ratio with PTH as a prognostic biomarker
#2578METHOD, KIT AND TEST STRIP FOR DETECTING KAWASAKI DISEASE
#2579Compositions and methods for treating eye infections and disease
#2580COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE
#2581BIOMARKERS AND METHODS OF PREDICTION
#2582Methods and compositions for diagnosis and management of diabetes and metabolic syndrome
#2583Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition
#2584BIOMARKERS USEFUL IN THE TREATMENT OF SUBJECTS HAVING RETINITS PIGMENTOSA
#2585METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#2586Detection of an immune response
#2587Pathway specific markers for diagnosing irritable bowel syndrome
#2588BIOMARKER FOR DETERMINING MITOCHONDRIAL DAMAGE IN FRIEDREICH'S ATAXIA
#2589Method and a kit to quantify and qualify exosomes for diagnosis of prostate cancer and prostate hyperplasia
#2590Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#2591Recombinant deamidated gliadin antigen
#2592Diagnostic method for parkinson's disease and lewy body dementia
#2593METHODS, SYSTEMS AND PRODUCTS FOR PREDICTING RESPONSE OF TUMOR CELLS TO A THERAPEUTIC AGENT AND TREATING A PATIENT ACCORDING TO THE PREDICTED RESPONSE
#2594Method of identifying risk for thyroid disorder
#2595Methods for Treating Sepsis and Biomarkers Related Thereto
#2596Method for diagnosing primary biliary cirrhosis (PBC) using novel autoantigens
#2597Methods for Increasing the Selective Efficacy of Gene Therapy Using CAR Peptide and Heparan Sulfate Mediated Macropinocytosis
#2598Method for identifying an agent for treating abnormal kidney function
#2599Methods and Monitoring of Treatment With A DLL4 Antagonist
#2600METHODS OF MONITORING FOR ADHERENCE TO ARIPIPRAZOLE THERAPY
#2601Host and intestinal microbiota derived metabolomic blood plasma signature for prior radiation injury
#2602CELL SENESCENCE MARKERS AS DIAGNOSTIC AND THERAPEUTIC TARGETS
#2603Algorithm of NTproBNP and hand held ECG to detect arrhythmia in an elderly population
#2604Method for determining the propensity for calcification
#2605HLA G-modified cells and methods
#2606Anticoagulant derivatives for cardiovascular imaging
#2607METHODS FOR PREDICTING AND IMPROVING THE SURVIVAL OF GASTRIC CANCER PATIENTS
#2608Reagents and methods for detecting PNH type II white blood cells and their identification as risk factors for thrombotic disorders
#2609RAC1 inhibitors for the treatment of Alport glomerular disease
#2610Analytical Methods and Arrays for Use in the Same
#2611Lung cancer differential marker
#2612Peptide inhibitors of calcium oxalate monohydrate crystallization and uses thereof
#2613Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors
#2614METHOD FOR ENHANCING IMMUNE CELL FUNCTION AND METHOD FOR ASSESSING IMMUNE CELL MULTIFUNCTIONALITY
#2615Methods and algorithms for aiding in the detection of cancer
#2616Compositions and methods for detecting anti-endothelial cell antibodies in allograft rejection
#2617PRECISE ESTIMATION OF GLOMERULAR FILTRATION RATE FROM MULTIPLE BIOMARKERS
#2618IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS
#2619CARDIOVASCULAR DISEASE PRIMARY PREVENTION AGENT FOR PATIENTS HAVING HIGH BLOOD LEVELS OF HIGH-SENSITIVITY C-REACTIVE PROTEIN
#2620Methods for differentiating ischemic stroke from hemorrhagic stroke
#2621Assessment of Heart Failure and Arrhythmic Risk Stratification by Measuring Circulating Hu Proteins
#2622ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) BIOMARKER PROTEINS
#2623Methods and compositions for the detection and diagnosis of renal disease and periodontal disease
#2624Nanoparticle probes and methods of making and use thereof
#2625Compositions and methods for diagnosis and treatment of metabolic syndrome
#2626Method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction
#2627Markers Associated With Arteriovascular Events And Methods Of Use Thereof
#2628METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#2629Biomarkers and assay to detect chronic graft versus host disease
#2630NT-pro ANP and SFlt-1 For The Differentiation Between Circulatory And Ischemic Events
#2631Methods and compositions for diagnosis and treatment of meningitis
#2632Methods of inhibiting pathological angiogenesis with doppel-targeting molecules
#2633ANNEXIN A2 AS IMMUNOLOGICAL TARGET
#2634METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#2635Neprilysin as heart failure prognostic marker
#2636Method for detecting and purifying pancreatic beta cells
#2637Antibodies that recognize a DENN/MADD-domain-containing 1A variant 2 (DENND1A variant 2)
#2638Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers
#2639Multivalent fibronectin-integrin binding compositions and methods of use thereof
#2640METHODS FOR EVALUATING RENAL INJURY AND RENAL FAILURE USING URINE LEVELS OF CHITINASE-3-LIKE PROTEIN 1
#2641Methods of detecting markers for inflammatory conditions and food sensitivity in companion animals
#2642Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#2643METHODS FOR DETECTING SINUSOIDAL OBSTRUCTIVE SYNDROME (SOS)
#2644Method and panel for determining acute kidney injury
#2645Method of predicting obesity comprising measuring neurotensin
#2646BIOMARKERS PREDICTIVE OF MUSCLE ATROPHY, METHOD AND USE
#2647METHODS FOR DIAGNOSIS, PROGNOSIS AND METHODS OF TREATMENT
#2648Methods and devices for multi-step cell purification and concentration
#2649TREATMENT OF MULTIPLE SCLEROSIS AND NEUROMYELITIS OPTICA
#2650Methods of treating inflammatory and autoimmune diseases with natalizumab
#2651METHODS OF TREATING OR PREVENTING PERIODONTITIS AND DISEASES ASSOCIATED WITH PERIODONTITIS
#2652Oligopeptidic compounds and uses thereof
#2653Presence of Phosphorylated Tau Protein in the Skin of Neurodegenerative Disease and SCIS, SCC, and BCC
#2654Method for Detection of Ischemic Strokes
#2655Compositions useful in the diagnostic of latently infected
#2656DIAGNOSTIC METHOD FOR DISORDERS USING COPEPTIN
#2657PROCESSES AND KITS TO DETECT AND MONITOR FOR DIAGNOSTIC BIOMARKERS FOR POST TRAUMATIC STRESS DISORDER (PTSD) AND TO DIFFERENTIATE BETWEEN SUICIDAL AND NON-SUICIDAL FORM OF THE DISORDER
#2658Diagnosis of sepsis and systemic inflammatory response syndrome
#2659Methods for in vitro investigating mitochondrial replication dysfunction in a biological sample, kits and uses thereof, therapeutic methods against progeroid-like syndromes or symptomes and screening method for identifying particular protease inhibitor(s) and/or nitroso-redox stress scavenger compound(s)
#2660Epithelial cell spheroids and methods of making and using the same
#2661COMPOSITIONS AND METHODS FOR IDENTIFYING AND TREATING CACHEXIA OR PRE-CACHEXIA
#2662Midkine antibody
#2663CENICRIVIROC FOR THE TREATMENT OF FIBROSIS
#2664COMPOSITIONS AND METHODS FOR THE REDUCTION OR PREVENTION OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)
#2665hGH Determination for Use to Guide Prevention of a Major Adverse Cardiac Event or a Cardiovascular Disease in a Subject
#2666Methods for assessing differential risk for developing heart failure
#2667METHOD FOR DETECTING A SPATIAL PROXIMITY OF A FIRST AND A SECOND EPITOPE
#2668Methods and kits for screening transplant recipients and candidates
#2669QUANTITATIVE LATERAL FLOW ASSAY
#2670Diagnostic method for distinguishing forms of esophageal eosinophilia
#2671METHODS OF DIAGNOSIS AND TREATMENT OF CELIAC DISEASE IN CHILDREN
#2672Synthetic active peptide fragments
#2673METHOD FOR ENHANCING IMMUNE CELL FUNCTION AND METHOD FOR ASSESSING IMMUNE CELL MULTIFUNCTIONALITY
#2674Diagnosis, and anti-mullerian hormone (AMH) administration for treatment, of infertility for good-, intermediate- and poor-prognosis patients for in vitro fertilization in view of logistic regression models
#2675Biomarkers for risk prediction of mortality
#2676Biomarkers of polycystic kidney disease and uses thereof
#2677Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) biomarkers and uses thereof
#2678PROTEIN AND GENE BIOMARKERS FOR REJECTION OF ORGAN TRANSPLANTS
#2679Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell
#2680Urinary crystal detection method
#2681Anti-complement C1s antibodies
#2682Immunological reagents
#2683Methods for treating cardiovascular dysfunction and improving fluid homeostasis with Elabela peptide hormone
#2684Methods for predicting risk of developing hypertension
#2685MARKERS FOR ATRIAL FIBRILLATION (AF)
#2686Kit for rapidly testing myocardial infarction and a preparation method and an application thereof
#2687METHODS FOR PREDICTING CLINICAL OUTCOMES IN SUBJECTS AFFLICTED WITH ULCERATIVE COLITIS
#2688Methods and kits for monitoring membranous nephropathy
#2689Substrate clearance assays for lysosomal enzymes
#2690Method for detecting sickle-cell disease and kit for implementing same
#2691Extreme ultraviolet radiation in genomic sequencing and other applications
#2692Method for treating and diagnosing disease using inhibitors of goodpasture antigen binding protein
#2693House dust mite allergen
#2694Use of fibroblast growth factor 2
#2695Automated immunoanalyzer system for performing diagnostic assays for allergies and autoimmune diseases
#2696Automated immunoanalyzer system for performing diagnostic assays for autoimmune and infectious diseases
#2697Quantifying biomarkers for diagnosing and treating schizophrenia, bipolar disorder or major depression
#2698Compositions, methods and kits for treating complement related disorders
#2699OSTEOPOROSIS ASSOCIATED MARKERS AND METHODS OF USE
#2700Markers for inflammatory bowel disease